Medication info
Telmisartan/Atorvastatin Calcium/Ezetimibe (unprocessed)/Amlodipine Besylate Tablets 80/20/10/5 mg

Telmisartan/Atorvastatin Calcium/Ezetimibe (unprocessed)/Amlodipine Besylate Tablets 80/20/10/5 mg

Prescription medicationTabletOral
Ingredient · strength
Telmisartan›80mg / 1 tabletRosuvastatin Calcium›20.8mg / 1 tabletEzetimibe›10mg / 1 tabletAmlodipine Besylate›6.944mg / 1 tablet
Manufacturer / importer
Jeil Pharmaceutical Co., Ltd.
Appearance
Pink oval film-coated tablet
Packaging
30 tablets/box [6 tablets/PTP X 5]
Approval status
Active

MFDS item code 202203055 · Approved 2022.07.21 · Insurance code 645406210

Summary

Main use
Treatment of essential hypertension and dyslipidemia (including hypercholesterolemia)
Who takes it
Adults
Adult dose
This medicine is for use in adults only. The dose should be individualized for each patient based on the efficacy and tolerability of the telmisartan/amlodipine combination and the rosuvastatin/ezetimibe combination. The recommended dose is 1 tablet once daily, taken with water, with or without food. It is recommended that the tablet be taken at the same time each day (e.g., in the morning), if possible. Swallow the tablet whole; do not chew, divide, or crush it. ○ Telmisartan/Amlodipine The recommended dose of the telmisartan/amlodipine combination is once daily. Before administering the telmisartan/amlodipine combination, it is recommended that the dose be adjusted using the individual components (amlodipine or telmisartan). However, if blood pressure is not controlled with the individual components as described below, switching directly to the telmisartan/amlodipine combination may be considered. - 40/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg. - 80/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or the telmisartan/amlodipine combination 40/5 mg. - 40/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg. ◦ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 mg in patients with mild or moderate hepatic impairment. ◦ Elderly patients: In patients aged 75 years or older, amlodipine clearance is reduced; therefore, treatment should be initiated at a low dose and the dose increased gradually. ○ Rosuvastatin/Ezetimibe Patients should follow a standard cholesterol-lowering diet before and during treatment with the rosuvastatin/ezetimibe combination. The dose of the rosuvastatin/ezetimibe combination should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response. Primary hypercholesterolemia The dose range of the rosuvastatin/ezetimibe combination is 5/10 mg to 20/10 mg once daily. The recommended starting dose is 5/10 mg once daily. The dose may be adjusted in patients who require a greater reduction in LDL cholesterol. After starting the rosuvastatin/ezetimibe combination or adjusting the dose, blood lipid levels should be checked at intervals of 4 weeks or more, and the dose adjusted accordingly. The dose may be increased up to a maximum of 20/10 mg daily. For patients taking the telmisartan/amlodipine combination together with the rosuvastatin/ezetimibe combination, switching to this medicine (a combination product with the same amounts of each active ingredient) may be considered for convenience.

Ingredients

Manufacturer
Jeil Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension and dyslipidemia (including hypercholesterolemia)

  • Essential hypertension
  • primary hypercholesterolemia
  • familial heterozygous hypercholesterolemia
  • non-familial hypercholesterolemia
  • mixed dyslipidemia
  • elevated total cholesterol
  • elevated LDL cholesterol
  • elevated Apo B protein
  • elevated triglycerides
  • elevated non-HDL cholesterol
View approved original text

This medication is used for patients who require simultaneous administration of telmisartan and amlodipine combination, as well as atorvastatin and ezetimibe combination. To effectively manage hypertension and dyslipidemia, this medication is recommended for patients who have previously used each drug alone but have not adequately controlled blood pressure or lipid levels. The telmisartan/amlodipine combination helps to appropriately manage blood pressure in patients with essential hypertension, and the atorvastatin/ezetimibe combination is effective in improving cholesterol and lipid levels in patients with primary hypercholesterolemia and mixed dyslipidemia. This medication works by reducing total cholesterol, LDL cholesterol, Apo B, triglycerides, and non-HDL cholesterol while increasing HDL cholesterol, thereby improving cardiovascular health in patients. Therefore, it is appropriate for patients who require simultaneous management of blood pressure and lipids and effectively improves these conditions.

How to take

Adult dose

This medicine is for use in adults only. The dose should be individualized for each patient based on the efficacy and tolerability of the telmisartan/amlodipine combination and the rosuvastatin/ezetimibe combination. The recommended dose is 1 tablet once daily, taken with water, with or without food. It is recommended that the tablet be taken at the same time each day (e.g., in the morning), if possible. Swallow the tablet whole; do not chew, divide, or crush it. ○ Telmisartan/Amlodipine The recommended dose of the telmisartan/amlodipine combination is once daily. Before administering the telmisartan/amlodipine combination, it is recommended that the dose be adjusted using the individual components (amlodipine or telmisartan). However, if blood pressure is not controlled with the individual components as described below, switching directly to the telmisartan/amlodipine combination may be considered. - 40/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg. - 80/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or the telmisartan/amlodipine combination 40/5 mg. - 40/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg. ◦ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 mg in patients with mild or moderate hepatic impairment. ◦ Elderly patients: In patients aged 75 years or older, amlodipine clearance is reduced; therefore, treatment should be initiated at a low dose and the dose increased gradually. ○ Rosuvastatin/Ezetimibe Patients should follow a standard cholesterol-lowering diet before and during treatment with the rosuvastatin/ezetimibe combination. The dose of the rosuvastatin/ezetimibe combination should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response. Primary hypercholesterolemia The dose range of the rosuvastatin/ezetimibe combination is 5/10 mg to 20/10 mg once daily. The recommended starting dose is 5/10 mg once daily. The dose may be adjusted in patients who require a greater reduction in LDL cholesterol. After starting the rosuvastatin/ezetimibe combination or adjusting the dose, blood lipid levels should be checked at intervals of 4 weeks or more, and the dose adjusted accordingly. The dose may be increased up to a maximum of 20/10 mg daily. For patients taking the telmisartan/amlodipine combination together with the rosuvastatin/ezetimibe combination, switching to this medicine (a combination product with the same amounts of each active ingredient) may be considered for convenience.

Precautions

This medication can cause serious harm to the fetus if taken during pregnancy, especially in the 2nd and 3rd trimesters, so treatment must be stopped immediately upon confirmation of pregnancy. Patients with muscle-related disorders, acute infections, hypotension, or recovering from surgery should temporarily stop or use this medication with caution due to the risk of muscle damage. It should not be administered to patients who have allergies to the components contained in this medication or have severely impaired liver function, and patients with serious kidney function impairment. Patients with diabetes or severe kidney impairment should also avoid concomitant use with specific ingredients, and pregnant or nursing women should not use this medication. Patients with slightly impaired liver function or elderly individuals should exercise caution and may require dose adjustments, and should consult a healthcare provider immediately if symptoms of muscle pain or weakness occur. This medication lowers blood pressure, so patients with hypotension or dehydration must stabilize their condition before starting treatment and regularly monitor blood pressure and kidney function during treatment. There is a risk of increased potassium levels in the blood, so caution is needed when taking it alongside potassium supplements or potassium-containing medications. Regular liver function and muscle-related tests should be conducted during treatment to detect adverse reactions early. Caution is needed while driving or operating machinery as dizziness or drowsiness may occur. When taking this medication with other drugs, it is advisable to consult a healthcare provider or pharmacist regarding potential interactions.

Side effects

Eyelid damage, head injury, dysuria, flushing, chronic gastritis, various gastrointestinal disorders, chest pain, facial edema, strange sensation, drug intolerance, irritable bowel syndrome, colon polyps, esophagitis, dizziness, somnolence, neurodegenerative disorders, postural dizziness, migraine, diabetes, glucose tolerance disorder, depression, bronchitis, rhinitis, cystitis, tinea unguium, soft tissue infection, hepatic steatosis, liver dysfunction, hepatotoxicity, acute hepatitis, toxic hepatitis, increased gamma-glutamyl transferase, increased blood cholesterol, increased alkaline phosphatase in blood, irregular heartbeat, osteoarthritis, osteoporosis, musculoskeletal stiffness, musculoskeletal discomfort, muscle weakness, cold sweat, dermatitis, skin burning sensation, skin disorders, alopecia, oropharyngeal pain, nasal congestion, respiratory distress, pelvic pain, breast cysts, eyelid droop, diabetic retinopathy, ear discomfort, renal dysfunction, benign esophageal neoplasm, upper respiratory infection, urinary tract infection, sepsis, anemia, thrombocytopenia, eosinophilia, hypersensitivity, anaphylactic reaction, hyperkalemia, hypoglycemia, depression, insomnia, anxiety, syncope, visual disturbances, dizziness, bradycardia, tachycardia, hypotension, orthostatic hypotension, dyspnea, abdominal pain, diarrhea, dyspepsia, abdominal bloating, vomiting, abdominal discomfort, dry mouth, liver function abnormalities, liver disease, increased sweating, itching, rash, erythema, angioedema, drug rash, toxic epidermal necrolysis, eczema, urticaria, myalgia, low back pain, muscle cramps, arthralgia, limb pain, tendon pain, acute renal failure, chest pain, weakness, influenza-like illness, increased serum creatinine, increased serum uric acid, elevated liver enzymes, increased serum creatine kinase levels, decreased hemoglobin, angioedema, vasculitis, hypertonia, sensory diminution, sensory abnormalities, peripheral neuropathy, dysgeusia, tremors, extrapyramidal disorders, erectile dysfunction, changes in bowel habits, gingival hyperplasia, pancreatitis, headache, fatigue, weight gain, weight loss, palpitations, thrombocytopenia, urticaria, hyperhidrosis, purpura, skin discoloration, toxic epidermal necrolysis, tinnitus, increased urinary frequency, urinary disorders, nocturia, hepatitis, jaundice, increased liver enzyme levels, myocardial infarction, arrhythmia, sinus block, atrioventricular block, precordial pain, loose stools, constipation, skin flushing, papular rash, dizziness, heat sensation, decreased glucose tolerance, weakness, headache, facial twitching, sensory abnormalities, paralysis, cough, hyperventilation, pneumonia, flushing, erectile dysfunction, appetite loss, facial edema, alopecia, conjunctivitis, petechiae, constipation, nausea, abdominal pain, pancreatitis, myopathy, rhabdomyolysis, weakness, arthralgia, myalgia, muscle cramps, myositis, muscle rupture, lupus-like syndrome, immune-mediated necrotizing myopathy, hematuria, edema, Stevens-Johnson syndrome, eosinophilia and systemic symptoms associated drug reaction syndrome, amnesia, polyneuropathy, peripheral neuropathy, diarrhea, jaundice, hepatitis, transaminase elevation, anaphylaxis, erythema multiforme, cholelithiasis, cholecystitis, tremors, diabetic neuropathy, epigastric pain, vomiting, gastritis, epigastric discomfort, belching, gastrointestinal disorders, palpitations, congestive heart failure, myocardial ischemia, sputum, runny nose, limb pain, uncomfortable chest, syncope, generalized pain, gout

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air and moisture, so it should be stored in a tightly sealed container. It is recommended to maintain the storage temperature between 1 and 30 degrees Celsius to preserve the medication’s effectiveness over a longer period.

Appearance and packaging

Appearance

Pink oval film-coated tablet

Package unit

30 tablets/box [6 tablets/PTP X 5]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.